A Study to Understand the Treatment Patterns in Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension During a Switch of Treatment to Adempas in Real-life Clinical Practice

CompletedOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

September 15, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

August 31, 2016

Conditions

Hypertension, Pulmonary

Interventions

DRUG

Riociguat (Adempas, BAY63-2521)

As per the treating physicians discretion

Trial Locations (7)

Many Locations